Clinical trial

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

NCT00006036

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-03-22

PhasePHASE1

Study timeline

Study start (actual)2000-03-22Date precision: day

Registry last updated2020-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Head and Neck Cancerunresolved

Lung Cancerunresolved

Ovarian Cancerunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

cisplatinDRUG · verified · RxNorm: cisplatin

lurtotecan liposomeDRUG

Sponsors & collaborators

NCIC Clinical Trials Grouplead sponsor

Mapped research locations

TorontoOntario, Canada1 VancouverBritish Columbia, Canada1 HamiltonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006036 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.